EX-99.1
2
a08-19595_1ex99d1.htm
EX-99.1
Exhibit 99.1
Contact:
Harvey Kamil
Carl
Hymans
NBTY, Inc.
G.S.
Schwartz & Co.
President &
Chief Financial Officer
212-725-4500
631-200-2020
carlh@schwartz.com
NBTY CLOSES ON PURCHASE OF LEINER
HEALTH PRODUCTS
RONKONKOMA,
N.Y. - July 14, 2008 - NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a
leading global manufacturer and marketer of nutritional supplements, today
announced that it has completed the purchase of substantially all of the assets
of Leiner Health Products Inc. for approximately $371 million. The
terms of the Asset Purchase Agreement
provide for various working capital adjustments.
NBTY
is acquiring substantially all of Leiner's assets, including its U.S. store
brand vitamins, minerals and supplements products as well as Vita Health
Products, Inc., Leiner's Canadian subsidiary.
Moelis &
Company LLC provided advisory services and Farrell Fritz, P.C. provided legal
advice in connection with the acquisition.
NBTY
Chairman and CEO, Scott Rudolph, said: "The
Leiner acquisition will further enhance our manufacturing capabilities and
dominant market presence as the worldwide leader in the nutritional supplement
industry. NBTY's history of successful
strategic acquisitions reflects our commitment to generating growth, providing
the highest quality service to our customers and increasing shareholder value".
About Leiner Health Products
Founded
in 1973 and headquartered in Carson, California, Leiner Health Products is
America's leading manufacturer of store brand vitamins, minerals, and
nutritional supplements and supplies the food, drug, mass merchant and
warehouse club retail market. Leiner
provides leading retailers with over 2,000 products to help its customers
create and market high-quality store brands at low prices. It is also the largest supplier to the U.S.
military and markets its own brand of vitamins under YourLife
®
.
ABOUT
NBTY
NBTY
is a leading global vertically integrated manufacturer, marketer and
distributor of a broad line of high-quality, value-priced nutritional
supplements in the United States and throughout the world. Under a number of
NBTY and third party brands, the Company offers over 22,000 products, including
products marketed by the Company's
Nature's Bounty
®
(www.NaturesBounty.com),
Vitamin World
® (www.VitaminWorld.com),
Puritan's
Pride
® (www.Puritan.com),
Holland & Barrett
®
(www.HollandAndBarrett.com),
Rexall
® (www.Rexall.com),
Sundown
®
(www.SundownNutrition.com),
MET-Rx
® (www.MetRX.com), Worldwide Sport
Nutrition® (www.SportNutrition.com),
American Health
® (www.AmericanHealthUS.com),
GNC
(UK)® (www.GNC.co.uk),
DeTuinen
® (www.DeTuinen.nl),
LeNaturiste
™
(www.LeNaturiste.com),
SISU
® (www.SISU.com),
Solgar
®
(www.Solgar.com), Good "n" Natural® (www.goodnnatural.com), Home Health™
(www.homehealthus.com) and
Ester-C
® (www.Ester-C.com) brands.
This
release contains certain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 with respect to our financial
condition, results of operations and business.
These forward-looking statements can be identified by the use of
terminology such as "subject to", "believe", "expects", "plan", "project", "estimate,"
"intend", "may", "will", "should", "can", or "anticipates", or the negative
thereof, or variations thereon, or comparable terminology, or by discussions of
strategy. Although all of these forward
looking statements are believed to be reasonable, they are inherently
uncertain. Factors which may materially
affect such forward-looking statements include: (i) slow or negative
growth in the nutritional supplement industry; (ii) interruption of
business or negative impact on sales and earnings due to acts of God, acts of
war, terrorism, bio-terrorism, civil unrest or disruption of mail service; (iii) adverse
publicity regarding nutritional supplements; (iv) inability to retain
customers of companies (or mailing lists) recently acquired; (v) increased
competition; (vi) increased costs; (vii) loss or retirement of key
members of management; (viii) increases in the cost of borrowings and/or unavailability
of additional debt or equity capital; (ix) unavailability of, or inability
to consummate, advantageous acquisitions in the future, including those that
may be subject to bankruptcy approval or the inability of NBTY to integrate
acquisitions into the mainstream of its business; (x) changes in general
worldwide economic and political conditions in the markets in which NBTY may
compete from time to time; (xi) the inability of NBTY to gain and/or hold
market share of its wholesale and/or retail customers anywhere in the world;
(xii) unavailability of electricity in certain geographical areas; (xiii) the
inability of NBTY to obtain and/or renew insurance and/or the costs of the
same; (xiv) exposure to and expense of defending and resolving product liability
and intellectual property claims and other litigation; (xv) the ability of NBTY
to successfully implement its business strategy; (xvi) the inability of NBTY to
manage its retail, wholesale, manufacturing and other operations efficiently;
(xvii) consumer acceptance of NBTY's products; (xviii) the inability of NBTY to
renew leases for its retail locations; (xix) the inability of NBTY's retail
stores to attain or maintain profitability; (xx) the absence of clinical trials
for many of NBTY's products; (xxi) sales and earnings volatility and/or trends
for the Company and its market segments; (xxii) the efficacy of NBTY's Internet
and on-line sales and marketing strategies; (xxiii) fluctuations in foreign
currencies, including the British pound, the Euro and the Canadian dollar;
(xxiv) import-export controls on sales to foreign countries; (xxv) the
inability of NBTY to secure favorable new sites for, and delays in opening, new
retail and manufacturing locations; (xxvi) introduction of and compliance with new
federal, state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world (including the banning of
products) and more particularly Good Manufacturing Practices in the United
States, the Food Supplements Directive and Traditional Herbal Medicinal
Products Directive in Europe and Section 404 requirements of the
Sarbanes-Oxley Act of 2002; (xxvii) the mix of NBTY's products and the profit
margins thereon; (xxviii) the availability and pricing of raw materials; (xxix)
risk factors discussed in NBTY's filings with the U.S. Securities and Exchange
Commission; (xxx) adverse effects on NBTY as a result of increased energy
prices and potentially reduced traffic flow to NBTY's retail locations; (xxxi)
adverse tax determinations; (xxxii) the loss of a significant customer of the
Company; (xxxiii) potential investment losses as a result of liquidity
conditions; and (xxxiv) other factors beyond the Company's control.
Readers are cautioned not to place undue reliance on forward-looking
statements. NBTY cannot guarantee future results, trends, events, levels of
activity, performance or achievements. NBTY does not undertake and specifically
declines any obligation to update, republish or revise forward-looking
statements to reflect events or circumstances after the date hereof or to
reflect the occurrences of unanticipated events.
Consequently, such forward-looking statements should
be regarded solely as NBTY's current plans, estimates and beliefs.

EX - 99 . 1 2 a08 - 19595 _ 1ex99d1 . htm EX - 99 . 1 Exhibit 99 . 1 Contact : Harvey Kamil Carl Hymans NBTY , Inc . G . S . Schwartz & Co . President & Chief Financial Officer 212 - 725 - 4500 631 - 200 - 2020 carlh@schwartz.com NBTY CLOSES ON PURCHASE OF LEINER HEALTH PRODUCTS RONKONKOMA , N . Y . - July 14 , 2008 - NBTY , Inc . ( NYSE : NTY ) ( www.NBTY.com ) , a leading global manufacturer and marketer of nutritional supplements , today announced that it has completed the purchase of substantially all of the assets of Leiner Health Products Inc . for approximately $ 371 million . The terms of the Asset Purchase Agreement provide for various working capital adjustments . NBTY is acquiring substantially all of Leiner 's assets , including its U . S . store brand vitamins , minerals and supplements products as well as Vita Health Products , Inc . , Leiner 's Canadian subsidiary . Moelis & Company LLC provided advisory services and Farrell Fritz , P . C . provided legal advice in connection with the acquisition . NBTY Chairman and CEO , Scott Rudolph , said : " The Leiner acquisition will further enhance our manufacturing capabilities and dominant market presence as the worldwide leader in the nutritional supplement industry . NBTY 's history of successful strategic acquisitions reflects our commitment to generating growth , providing the highest quality service to our customers and increasing shareholder value " . About Leiner Health Products Founded in 1973 and headquartered in Carson , California , Leiner Health Products is America 's leading manufacturer of store brand vitamins , minerals , and nutritional supplements and supplies the food , drug , mass merchant and warehouse club retail market . Leiner provides leading retailers with over 2,000 products to help its customers create and market high - quality store brands at low prices . It is also the largest supplier to the U . S . military and markets its own brand of vitamins under YourLife ® . ABOUT NBTY NBTY is a leading global vertically integrated manufacturer , marketer and distributor of a broad line of high - quality , value - priced nutritional supplements in the United States and throughout the world . Under a number of NBTY and third party brands , the Company offers over 22,000 products , including products marketed by the Company 's Nature 's Bounty ® ( www.NaturesBounty.com ) , Vitamin World ® ( www.VitaminWorld.com ) , Puritan 's Pride ® ( www.Puritan.com ) , Holland & Barrett ® ( www.HollandAndBarrett.com ) , Rexall ® ( www.Rexall.com ) , Sundown ® ( www.SundownNutrition.com ) , MET - Rx ® ( www.MetRX.com ) , Worldwide Sport Nutrition ® ( www.SportNutrition.com ) , American Health ® ( www.AmericanHealthUS.com ) , GNC ( UK ) ® ( www.GNC.co.uk ) , DeTuinen ® ( www.DeTuinen.nl ) , LeNaturiste ™ ( www.LeNaturiste.com ) , SISU ® ( www.SISU.com ) , Solgar ® ( www.Solgar.com ) , Good " n " Natural ® ( www.goodnnatural.com ) , Home Health™ ( www.homehealthus.com ) and Ester - C ® ( www.Ester-C.com ) brands . This release contains certain forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition , results of operations and business . These forward - looking statements can be identified by the use of terminology such as " subject to " , " believe " , " expects " , " plan " , " project " , " estimate , " " intend " , " may " , " will " , " should " , " can " , or " anticipates " , or the negative thereof , or variations thereon , or comparable terminology , or by discussions of strategy . Although all of these forward looking statements are believed to be reasonable , they are inherently uncertain . Factors which may materially affect such forward - looking statements include : ( i ) slow or negative growth in the nutritional supplement industry ; ( ii ) interruption of business or negative impact on sales and earnings due to acts of God , acts of war , terrorism , bio - terrorism , civil unrest or disruption of mail service ; ( iii ) adverse publicity regarding nutritional supplements ; ( iv ) inability to retain customers of companies ( or mailing lists ) recently acquired ; ( v ) increased competition ; ( vi ) increased costs ; ( vii ) loss or retirement of key members of management ; ( viii ) increases in the cost of borrowings and / or unavailability of additional debt or equity capital ; ( ix ) unavailability of , or inability to consummate , advantageous acquisitions in the future , including those that may be subject to bankruptcy approval or the inability of NBTY to integrate acquisitions into the mainstream of its business ; ( x ) changes in general worldwide economic and political conditions in the markets in which NBTY may compete from time to time ; ( xi ) the inability of NBTY to gain and / or hold market share of its wholesale and / or retail customers anywhere in the world ; ( xii ) unavailability of electricity in certain geographical areas ; ( xiii ) the inability of NBTY to obtain and / or renew insurance and / or the costs of the same ; ( xiv ) exposure to and expense of defending and resolving product liability and intellectual property claims and other litigation ; ( xv ) the ability of NBTY to successfully implement its business strategy ; ( xvi ) the inability of NBTY to manage its retail , wholesale , manufacturing and other operations efficiently ; ( xvii ) consumer acceptance of NBTY 's products ; ( xviii ) the inability of NBTY to renew leases for its retail locations ; ( xix ) the inability of NBTY 's retail stores to attain or maintain profitability ; ( xx ) the absence of clinical trials for many of NBTY 's products ; ( xxi ) sales and earnings volatility and / or trends for the Company and its market segments ; ( xxii ) the efficacy of NBTY 's Internet and on - line sales and marketing strategies ; ( xxiii ) fluctuations in foreign currencies , including the British pound , the Euro and the Canadian dollar ; ( xxiv ) import - export controls on sales to foreign countries ; ( xxv ) the inability of NBTY to secure favorable new sites for , and delays in opening , new retail and manufacturing locations ; ( xxvi ) introduction of and compliance with new federal , state , local or foreign legislation or regulation or adverse determinations by regulators anywhere in the world ( including the banning of products ) and more particularly Good Manufacturing Practices in the United States , the Food Supplements Directive and Traditional Herbal Medicinal Products Directive in Europe and Section 404 requirements of the Sarbanes - Oxley Act of 2002 ; ( xxvii ) the mix of NBTY 's products and the profit margins thereon ; ( xxviii ) the availability and pricing of raw materials ; ( xxix ) risk factors discussed in NBTY 's filings with the U . S . Securities and Exchange Commission ; ( xxx ) adverse effects on NBTY as a result of increased energy prices and potentially reduced traffic flow to NBTY 's retail locations ; ( xxxi ) adverse tax determinations ; ( xxxii ) the loss of a significant customer of the Company ; ( xxxiii ) potential investment losses as a result of liquidity conditions ; and ( xxxiv ) other factors beyond the Company 's control . Readers are cautioned not to place undue reliance on forward - looking statements . NBTY can not guarantee future results , trends , events , levels of activity , performance or achievements . NBTY does not undertake and specifically declines any obligation to update , republish or revise forward - looking statements to reflect events or circumstances after the date hereof or to reflect the occurrences of unanticipated events . Consequently , such forward - looking statements should be regarded solely as NBTY 's current plans , estimates and beliefs .